Cargando…

Tumor track seeding: A new complication of fiducial marker insertion

In the United States, lung cancer is the leading cause of cancer-related death. Candidates for tumor ablation using CyberKnife® require fiducial placement in or near the target tumor to achieve precision. Placing these reference points may lead to complications including pneumothorax and/or hemorrha...

Descripción completa

Detalles Bibliográficos
Autores principales: Patel, Zeal, Retrouvey, Michele, Vingan, Harlan, Williams, Scott
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2015
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861831/
https://www.ncbi.nlm.nih.gov/pubmed/27186243
http://dx.doi.org/10.2484/rcr.v9i2.928
_version_ 1782431261328932864
author Patel, Zeal
Retrouvey, Michele
Vingan, Harlan
Williams, Scott
author_facet Patel, Zeal
Retrouvey, Michele
Vingan, Harlan
Williams, Scott
author_sort Patel, Zeal
collection PubMed
description In the United States, lung cancer is the leading cause of cancer-related death. Candidates for tumor ablation using CyberKnife® require fiducial placement in or near the target tumor to achieve precision. Placing these reference points may lead to complications including pneumothorax and/or hemorrhage. We report a new complication: the appearance of metastatic foci along the track of the fiducial marker. Since the marker was inserted by traversing the original primary tumor, we hypothesize that malignant cells were seeded along the track. In light of this new complication, current techniques for the insertion of fiducial markers should consider a peripheral approach when possible to avoid tracking of malignant cells.
format Online
Article
Text
id pubmed-4861831
institution National Center for Biotechnology Information
language English
publishDate 2015
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-48618312016-05-16 Tumor track seeding: A new complication of fiducial marker insertion Patel, Zeal Retrouvey, Michele Vingan, Harlan Williams, Scott Radiol Case Rep Article In the United States, lung cancer is the leading cause of cancer-related death. Candidates for tumor ablation using CyberKnife® require fiducial placement in or near the target tumor to achieve precision. Placing these reference points may lead to complications including pneumothorax and/or hemorrhage. We report a new complication: the appearance of metastatic foci along the track of the fiducial marker. Since the marker was inserted by traversing the original primary tumor, we hypothesize that malignant cells were seeded along the track. In light of this new complication, current techniques for the insertion of fiducial markers should consider a peripheral approach when possible to avoid tracking of malignant cells. Elsevier 2015-12-07 /pmc/articles/PMC4861831/ /pubmed/27186243 http://dx.doi.org/10.2484/rcr.v9i2.928 Text en © 2014 The Authors. http://creativecommons.org/licenses/by-nc-nd/4.0/ This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Article
Patel, Zeal
Retrouvey, Michele
Vingan, Harlan
Williams, Scott
Tumor track seeding: A new complication of fiducial marker insertion
title Tumor track seeding: A new complication of fiducial marker insertion
title_full Tumor track seeding: A new complication of fiducial marker insertion
title_fullStr Tumor track seeding: A new complication of fiducial marker insertion
title_full_unstemmed Tumor track seeding: A new complication of fiducial marker insertion
title_short Tumor track seeding: A new complication of fiducial marker insertion
title_sort tumor track seeding: a new complication of fiducial marker insertion
topic Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4861831/
https://www.ncbi.nlm.nih.gov/pubmed/27186243
http://dx.doi.org/10.2484/rcr.v9i2.928
work_keys_str_mv AT patelzeal tumortrackseedinganewcomplicationoffiducialmarkerinsertion
AT retrouveymichele tumortrackseedinganewcomplicationoffiducialmarkerinsertion
AT vinganharlan tumortrackseedinganewcomplicationoffiducialmarkerinsertion
AT williamsscott tumortrackseedinganewcomplicationoffiducialmarkerinsertion